hypericin has been researched along with Liver Neoplasms in 5 studies
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypericin has an excellent necrosis-specific targeting capacity; thus, we explored small-molecular tumor necrosis therapy (SMTNT) for inhibiting tumor growth in rodent tumor models." | 7.81 | Biodistribution and anti-tumor efficacy of intratumorally injected necrosis-avid theranostic agent radioiodinated hypericin in rodent tumor models. ( Feng, Y; Gao, M; Huang, D; Jiang, C; Jiang, X; Jing, S; Li, Y; Liu, W; Ni, Y; Peng, F; Wang, X; Zhang, D; Zhang, J, 2015) |
| "Hypericin has an excellent necrosis-specific targeting capacity; thus, we explored small-molecular tumor necrosis therapy (SMTNT) for inhibiting tumor growth in rodent tumor models." | 3.81 | Biodistribution and anti-tumor efficacy of intratumorally injected necrosis-avid theranostic agent radioiodinated hypericin in rodent tumor models. ( Feng, Y; Gao, M; Huang, D; Jiang, C; Jiang, X; Jing, S; Li, Y; Liu, W; Ni, Y; Peng, F; Wang, X; Zhang, D; Zhang, J, 2015) |
| "Seven mice bearing intrahepatic radiation-induced fibrosarcoma-1 tumors were intravenously injected with hypericin 1 hour before (n = 3) or 24 hours after (n = 4) intratumoral ethanol injection." | 3.74 | Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model. ( Chen, F; de Witte, PA; Ni, Y; Van de Putte, M; Wang, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelsalam, AM | 1 |
| Somaida, A | 1 |
| Ambreen, G | 1 |
| Ayoub, AM | 1 |
| Tariq, I | 1 |
| Engelhardt, K | 1 |
| Garidel, P | 1 |
| Fawaz, I | 1 |
| Amin, MU | 1 |
| Wojcik, M | 1 |
| Bakowsky, U | 1 |
| Liu, W | 1 |
| Zhang, D | 1 |
| Feng, Y | 1 |
| Li, Y | 1 |
| Huang, D | 1 |
| Jiang, C | 1 |
| Gao, M | 1 |
| Peng, F | 1 |
| Wang, X | 1 |
| Jing, S | 1 |
| Jiang, X | 1 |
| Ni, Y | 2 |
| Zhang, J | 1 |
| Seitz, G | 1 |
| Krause, R | 1 |
| Fuchs, J | 1 |
| Heitmann, H | 1 |
| Armeanu, S | 1 |
| Ruck, P | 1 |
| Warmann, SW | 1 |
| Fadel, M | 1 |
| Kassab, K | 1 |
| Youssef, T | 1 |
| Van de Putte, M | 1 |
| Wang, H | 1 |
| Chen, F | 1 |
| de Witte, PA | 1 |
5 other studies available for hypericin and Liver Neoplasms
| Article | Year |
|---|---|
Surface tailored zein as a novel delivery system for hypericin: Application in photodynamic therapy.
Topics: Animals; Anthracenes; Liver Neoplasms; Mice; Perylene; Photochemotherapy; Photosensitizing Agents; S | 2021 |
Biodistribution and anti-tumor efficacy of intratumorally injected necrosis-avid theranostic agent radioiodinated hypericin in rodent tumor models.
Topics: Animals; Anthracenes; Antineoplastic Agents; Autoradiography; Carcinoma, Hepatocellular; Cell Line, | 2015 |
In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin.
Topics: Anthracenes; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Surviv | 2008 |
Photodynamic efficacy of hypericin targeted by two delivery techniques to hepatocellular carcinoma cells.
Topics: Anthracenes; Antibodies, Monoclonal; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Delivery Syst | 2010 |
Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model.
Topics: Analysis of Variance; Animals; Anthracenes; Antineoplastic Agents; Disease Models, Animal; Ethanol; | 2008 |